GLYCINOROM M OD 30 TAB 10 S

About

Gliclazide is a second-generation sulfonylurea oral hypoglycemic agent primarily used in the management of type 2 diabetes mellitus. It works by stimulating the beta cells of the pancreas to release insulin, particularly in the presence of glucose, thereby lowering blood glucose levels. The modified-release (MR) formulation of Gliclazide 30mg allows for once-daily dosing, providing sustained glycemic control throughout the day and night. This sustained action helps to maintain more stable blood sugar levels and reduces the risk of post-meal glucose spikes. It is typically prescribed when diet and exercise alone are insufficient to achieve adequate glycemic control. Gliclazide also exhibits some extrapancreatic effects, including improving peripheral insulin sensitivity and reducing hepatic glucose production, contributing to its overall efficacy in managing hyperglycemia and achieving target HbA1c levels, which is crucial for preventing long-term diabetic complications.

Uses

• Management of type 2 diabetes mellitus.
• When diet and exercise are insufficient.
• To lower elevated blood glucose levels.
• As part of a comprehensive diabetes management plan.

Directions For Use

Take orally once daily, preferably with breakfast, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Effective reduction in blood glucose levels.
• Helps achieve target HbA1c.
• Once-daily dosing for convenience.
• Provides sustained glycemic control.
• Reduces risk of long-term diabetic complications.
• May have some antioxidant properties.

Side Effects

• Hypoglycemia (low blood sugar)
• Gastrointestinal disturbances (nausea, diarrhea)
• Abdominal pain
• Skin rash or itching
• Headache
• Dizziness
• Weight gain
• Allergic reactions
• Liver enzyme elevation
• Blood dyscrasias (rare)
• Visual disturbances
• Fatigue

Safety Measures

• Alcohol - Alcohol can increase the risk of hypoglycemia when taken with gliclazide. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - Gliclazide is generally not recommended during pregnancy. Insulin therapy is usually preferred. Consult your doctor.
• Breastfeeding - Gliclazide may pass into breast milk. It is generally not recommended during breastfeeding. Consult your doctor.
• Liver - Use with caution in patients with liver impairment as it can affect drug metabolism and increase hypoglycemia risk. Dose adjustment may be necessary.
• Kidney - Use with caution in patients with moderate to severe kidney impairment. Dose adjustment may be required to avoid drug accumulation and hypoglycemia.
• Lung - No direct specific contraindication for lung conditions, but severe respiratory illness may impact overall health and diabetes management.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.